Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Labcorp Holdings Allowance for Doubtful Accounts Receivable (Current) decreased by 9.3% to $33.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.5%, from $38.60M to $33.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 10.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.90M | $18.30M | $21.50M | $19.40M | $21.30M | $20.50M | $30.70M | $52.80M | $30.60M | $32.80M | $32.70M | $34.20M | $34.10M | $38.90M | $44.70M | $38.60M | $40.10M | $36.70M | $36.40M | $33.00M |
| QoQ Change | — | -12.4% | +17.5% | -9.8% | +9.8% | -3.8% | +49.8% | +72.0% | -42.0% | +7.2% | -0.3% | +4.6% | -0.3% | +14.1% | +14.9% | -13.6% | +3.9% | -8.5% | -0.8% | -9.3% |
| YoY Change | — | — | — | — | +1.9% | +12.0% | +42.8% | +172.2% | +43.7% | +60.0% | +6.5% | -35.2% | +11.4% | +18.6% | +36.7% | +12.9% | +17.6% | -5.7% | -18.6% | -14.5% |
Business Segments
| Segment | Q4 '24 | Q4 '25 |
|---|---|---|
| Biopharma Laboratory Services | $44.70M | $36.40M |
| Total | $44.70M | $36.40M |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's allowance for doubtful accounts receivable (current)?
- Labcorp Holdings (LH) reported allowance for doubtful accounts receivable (current) of $33.00M in Q1 2026.
- How has Labcorp Holdings's allowance for doubtful accounts receivable (current) changed year-over-year?
- Labcorp Holdings's allowance for doubtful accounts receivable (current) decreased by 14.5% year-over-year, from $38.60M to $33.00M.
- What is the long-term trend for Labcorp Holdings's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Labcorp Holdings's allowance for doubtful accounts receivable (current) has grown at a 10.5% compound annual growth rate (CAGR), from $22.10M to $36.40M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.